Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitors
- 1 January 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 161, 543-558
Abstract
No abstract availableKeywords
Funding Information
- key project of Zhejiang Provincial Natural Science Foundation of China (LZ15H300001)
This publication has 31 references indexed in Scilit:
- Oxadiazoles in Medicinal ChemistryJournal of Medicinal Chemistry, 2012
- Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasomeBioorganic & Medicinal Chemistry Letters, 2010
- Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunitBiochemical Journal, 2010
- Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasomeBlood, 2009
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking AccuracyJournal of Medicinal Chemistry, 2004
- The Structure of the Mammalian 20S Proteasome at 2.75 Å ResolutionStructure, 2002
- Structure-Based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-Like activity of the human 20S proteasomeBioorganic & Medicinal Chemistry Letters, 2002
- THE UBIQUITIN SYSTEMAnnual Review of Biochemistry, 1998
- How Proteolysis Drives the Cell CycleScience, 1996
- Proteolysis: The proteasome: a protein-degrading organelle?Current Biology, 1995